Organization Overview
Historical Acquisition Tree
Alternative names
caplacizumab (cablivi) (2019 NDA)
Angina Pectoris (Phase 2)
Angina, Stable (Phase 2)
Angina, Unstable (Phase 2)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Communicable Diseases (Phase 2)
Infarction (Phase 2)
Infections (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Myocardial Infarction (Phase 2)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Respiratory Syncytial Virus Infections (Phase 1)
Respiratory Tract Infections (Phase 2)
Virus Diseases (Phase 1)